The timing appears opportune to go long in shares of The Scotts Miracle-Gro Company as we anticipate another pick-up in the underlying trend. Investors should buy the stock at current prices near $ 151 in order to target the $ 177.
In a short-term perspective, the company has interesting fundamentals.
The Scotts Miracle-Gro Company accounts for 5.31 % of our USA Portfolio. A trade is currently open since 06/11/2020 with a purchase price of $ 137.99. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 117.78 USD
The stock is close to a major daily resistance at USD 162.52, which should be gotten rid of so as to gain new appreciation potential.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.